BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Hybrigenics Re-brands to ‘ATON’ as Company Signals New Global Vision and Strategy to Advance Breakthrough Treatments

  Hybrigenics, a leading French publicly listed bioscience firm, has today announced its re-brand to ‘ATON’ as it signifies the culmination of a transformative shift in its vision and strategy that began two years ago.

  September 26, 2023

   · 

  4 min read
• Policy

  CEL-SCI Submits Scientific Advice Filing to European Medicines Agency (EMA) for Multikine in the Treatment of Head & Neck Cancer

  CEL-SCI Corporation reported it has filed a request for Scientific Advice regarding Multikine* immunotherapy for the treatment of newly diagnosed locally advanced squamous cell carcinoma of the head and neck with the European Medicines Agency’s Scientific Advice Working Group.

  September 26, 2023

   · 

  4 min read
• BioMidwest

  Industry Leader Harshal Shah Joins Battelle to Lead Medical Device Solutions Business

  Battelle announced that Harshal Shah has been selected to lead Battelle’s Medical Device Solutions business.

  September 26, 2023

   · 

  2 min read
• Biotech Beach

  SpineX Receives NIH SBIR Phase II Award for SCiP Clinical Trial in Children With CP

  SpineX Inc., a clinical stage bioelectric medtech company, is pleased to announce receipt of funding from the National Institutes of Health (NIH) through the Small Business Innovation Research Awards (SBIR).

  September 26, 2023

   · 

  2 min read
• BioForest

  Projects launch to map brain connections in mouse and macaque

  A complete map of all the connections in an entire mammalian brain may be in sight.

  September 26, 2023

   · 

  6 min read
• Pharm Country

  Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens

  Voltron Therapeutics, a Lucius Partners portfolio company, presented new evidence that demonstrates its VaxCelerate Vaccine platform’s superiority in driving effective T cell responses against lethal viral pathogens at the August 2023 Military Health System Research Symposium (MHSRS) in Orlando, Florida.

  September 26, 2023

   · 

  6 min read
• Business

  Mati Therapeutics Announces Promotion of Chris Muller to Chief Operating Officer

  Mati Therapeutics Inc. announced that it has promoted Chris Muller to the position of Chief Operating Officer.

  September 26, 2023

   · 

  3 min read
• Deals

  Varian Acquires Aspekt Solutions, Strengthening Advanced Oncology Solutions Offering

  Varian, a Siemens Healthineers company, announced today that it has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services.

  September 26, 2023

   · 

  3 min read
• Drug Development

  Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome

  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results for the Phase 3 Balance study of olezarsen in people with familial chylomicronemia syndrome (FCS).

  September 26, 2023

   · 

  8 min read
• Business

  Health Gorilla and Amwell Announce Expanded Digital Diagnostic Lab Ordering for Clinicians

  With a more connected and efficient digital lab process, Health Gorilla and Amwell reinforce their commitment to accessible hybrid care.

  September 26, 2023

   · 

  4 min read